EPCAM and lung carcinoma: Blood exosomes from 30 breast cancer patients, 30 colorectal cancer patients, 30 lung cancer patients, and 39 healthy controls were collected and quantified for PD-L1, EpCAM, and EGFR, showing that the expression of these genes was increased in cancer patients.